Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details 2)

v3.21.1
Stock Based Compensation (Details 2) - $ / shares
3 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Outstanding at 03/31/2021 1,006,397 992,397 719,400
0.0067 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Outstanding at 03/31/2021 820,391    
Weighted Average Remaining Contractual Life (years) 3 years 11 months 1 day    
Weighted Average Exercise Price $ 0.0067    
Shares Exercisable at 03/31/2021 820,391    
Weighted Average Remaining Contractual Life (years) 3 years 11 months 1 day    
Weighted Average Exercise Price $ 0.0067    
3.3521 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Outstanding at 03/31/2021 111,871    
Weighted Average Remaining Contractual Life (years) 5 years 2 months 30 days    
Weighted Average Exercise Price $ 3.3521    
Shares Exercisable at 03/31/2021 111,871    
Weighted Average Remaining Contractual Life (years) 5 years 2 months 30 days    
Weighted Average Exercise Price $ 3.3521    
Total [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Outstanding at 03/31/2021 932,262    
Weighted Average Remaining Contractual Life (years) 4 years 29 days    
Weighted Average Exercise Price $ 0.4081    
Shares Exercisable at 03/31/2021 932,262    
Weighted Average Remaining Contractual Life (years) 4 years 29 days    
Weighted Average Exercise Price $ 0.4081